Jennifer Peppe - 15 Aug 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Role
Global Head, Clinical Operations
Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Jennifer Peppe
Issuer symbol
N/A
Transactions as of
15 Aug 2022
Net transactions value
-$94,529
Form type
4
Filing time
16 Aug 2022, 16:08:23 UTC
Previous filing
15 Feb 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Options Exercise $14,107 +5,598 +3.8% $2.52* 154,407 15 Aug 2022 Direct F1
transaction IMGO Common Stock Sale $108,636 -5,598 -3.6% $19.41 148,809 15 Aug 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -5,598 -7.9% $0.000000 64,953 15 Aug 2022 Common Stock 5,598 $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $19.40 to $19.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Remarks:

Global Head, Clinical Operations